NCT00234923View on ClinicalTrials.gov

Efficacy and Safety of Kaletra Monotheraphy Compared to Kaletra Based Triple Therapy to Treat HIV in Antiretroviral Naїve Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

138

Participants

Timeline

Start Date

August 31, 2003

Primary Completion Date

February 28, 2007

Conditions
HIV Infection
Interventions
DRUG

lopinavir/ritonavir

400 mg lopinavir/ 100 mg ritonavir, BID

DRUG

lamivudine/zidovudine

300mg lamivudine/150mg zidovudine, BID

Sponsors

Lead Sponsor

Abbott
All Listed Sponsors
lead

Abbott

INDUSTRY